
About 69% of patients with CIU were either obese or overweight, and experienced a longer duration of disease than those who had lower weight values.
Jonathan Alicea is an assistant editor for HCPLive. He graduated from Princeton University with a degree with English and minors in Linguistics and Theater. He spends his free time writing plays, playing PlayStation, enjoying the company of his 2 pugs, and navigating a right-handed world as a lefty. You can email him at [email protected].

About 69% of patients with CIU were either obese or overweight, and experienced a longer duration of disease than those who had lower weight values.

TLR9 activation shows potential as a target for ulcerative colitis and warrants further testing.

The new dermatology podcast series will launch this month and will be hosted by dermatologist and professor Dr. Brad Glick.

Although sickle cell disease is the most common inherited blood disorder in the US, there are still knowledge and prioritization gaps that need to be addressed.

Paul Christo, MD, discusses opioid addiction during the pandemic, the role of the clinician, and offers a hopeful outlook for the future.

Cytokinetics announces presentations on two trials assessing omecamtiv mecarbil in patients with heart failure and reduced ejection fraction.

An expert discusses trends in pediatric mental health and receipt of treatment.

An expert discusses steps the FDA can take to strengthen and make more airtight their process for approving new opioids.

An expert discusses the effect the pandemic has had on opioid use and related deaths.

Higher levels of acetaminophen detected in meconium was linked to increased odds of developing ADHD by 6-7 years old.

A pharmacoepidemiologist offers his comments on the ongoing opioid epidemic.

These disparities were noted between age groups, sex, race/ethnicity, and urbanization level of residence.

An expert discusses how allergies can make it easier for viruses to enter the body as well as the association between asthma and COVID-19 severity.

The complexities associated with the disease and lack of validated risk predictors makes such a model challenging to implement.

Ongoing trials are essential to confirming semalutide’s role in decreasing risk of chronic kidney disease in patients with type 2 diabetes

A new cross-sectional study uncovers shortcomings in pivotal trials supporting new drug applications for opioid analgesics, which range from study design to duration.

These recommendations were developed with the primary goal of improving outcomes in cardiovascular mortality.

Between 1999 and 2016, cardiovascular disease prevalence declined at a much faster for the highest-income earners than the rest of the population.

Educating patients of the immune system can be helpful in addressing any concerns over getting vaccinated for the flu.

A study found that patients more commonly self-reported unintentional barriers to treatment adherence—such as forgetfulness and external influences—than intentional ones.

Ketotifen fumarate ophthalmic solution 0.035% is the first and only over-the-counter preservative-free eye drop solution for itchy eyes caused by allergies.

Testing all IBD patients for CMV can lead to a concerning overconsumption of resources as well as a delay in treatment.

An expert discusses the importance of getting vaccinated for the flu this year as well as strategies healthcare systems are taking to ensure easy access for patients.

These discrepancies are more pronounced in young, adolescent females and older adolescent males.

D. farinae and D. pteronyssinus positive skin prick test results were much more frequent in patients >18 years.

This decrease in hospital admissions had no association with regional prevalence of COVID-19.

About 2/3 of children with asthma had been exposed to opioids prior to birth, according to a new retrospective study.

Gene addition and editing strategies have potential of curing sickle cell disease and transfusion-dependent thalassemia, but there are still many obstacles that must be overcome.

According to a retrospective claims database study, as many as 43.8% of assessed patients with open-angle glaucoma required a change from initial treatment.

Individuals in vulnerable populations had a higher proportion and odds of not being vaccinated within the past year.